Načítá se...
Serendipity in splendid isolation: rapamycin
In this issue of Blood, Bride et al report results of the first prospective multi-institutional trial of a long-term single-agent therapy for refractory cytopenias using rapamycin in 30 patients and show remarkable efficacy in children with autoimmune lymphoproliferative syndrome (ALPS).(1)
Uloženo v:
| Vydáno v: | Blood |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society of Hematology
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4705609/ https://ncbi.nlm.nih.gov/pubmed/26744433 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-11-679829 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|